tm logo
TPU PHARMA
Live/Registered
REGISTERED

on 09 Jan 2024

Last Applicant/ Owned by

1718 Ringwood Avenue

San Jose

CA

951311711

Serial Number

90980667 filed on 12th Oct 2020

Registration Number

7270464 registered on 09th Jan 2024

in the Principal Register

Correspondent Address

Bret E. Field

Bret E. Field

201 REDWOOD SHORES PARKWAY, SUITE 200

REDWOOD CITY, CA, 94065

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

TPU PHARMA

Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics


First Use Date in General

13th Nov 2023

First Use Date in Commerce

13th Nov 2023

Mark Details


Serial Number

No 90980667

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TEIK-T030US2

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Jan 2024REGISTERED-PRINCIPAL REGISTER
09th Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
08th Dec 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07th Dec 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01st Dec 2023DIVISIONAL PROCESSING COMPLETE
01st Dec 2023STATEMENT OF USE PROCESSING COMPLETE
29th Nov 2023DIVISIONAL REQUEST RECEIVED
27th Nov 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
14th Nov 2023TEAS STATEMENT OF USE RECEIVED
14th Nov 2023TEAS REQUEST TO DIVIDE RECEIVED